Parexel and Veeva Systems are set to accelerate clinical trials through technology and process innovation, as part of a strategic collaboration.
Under the collaboration, the expertise of each company will be combined to improve study efficiency and quickly get new treatments to patients.
Parexel will streamline operations by standardising on Veeva Vault eTMF, Vault CTMS, and Vault Study Startup clinical operations applications.
Parexel will also provide Veeva Vault CDMS for clinical data management as a standard offering to its customers.
Parexel CEO Jamie Macdonald said: “By adopting Veeva’s clinical solutions we will streamline trial processes, drive greater efficiency, and make trial execution and participation easier for sponsors, sites, and patients.
“Through this expanded partnership with Veeva, we expect to deliver greater value for customers and make an even bigger impact on patients’ lives.”
The companies will obtain insights from sponsors, sites and patients and collaborate to continuously improve the cloud technology and processes for clinical trials delivery for Veeva and Parexel, respectively.
Parexel will also get early access and provide input into Veeva’s clinical products, which include innovations, for offering support to sites and patients in decentralised clinical trials, risk-based quality management, and community-based sites.
Veeva Systems founder and CEO Peter Gassner said: “We’re proud to partner with Parexel to drive customer success and speed innovations in clinical research.
“Together, we can accelerate how our customers bring new vaccines, diagnostics, devices, and therapies to patients in need.”
Last month, Korean contract research organisation LSK Global Pharma Services adopted Veeva Vault eTMF, Veeva Vault CTMS, and Veeva SiteVault Free clinical applications to streamline the global trial processes.